FLC
CHRS icon

Fifth Lane Capital’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Fifth Lane Capital’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-691,703
Closed – – 112
2023
Q4 		$0 Hold
691,703
– – ﹤0.01% 91
2023
Q3 		$0 Buy
+691,703
New – ﹤0.01% 168